FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Marie Derocq

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Transfection

Co-author Network

Publications

TOP 3
Bernard Bourrie; Estelle Bribes; Jean-Marie Derocq; Hubert Vidal; Pierre Casellas
Sigma receptor ligands: applications in inflammation and oncology.
Jean-Marie Derocq; Omar Jbilo; Monsif Bouaboula; M Ségui; C Clère; Pierre Casellas
Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation.
Omar Jbilo; Jean-Marie Derocq; M Segui; Gérard Le-Fur; Pierre Casellas
Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Marie Derocq (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Bernard Bourrie; Estelle Bribes; Jean-Marie Derocq; Hubert Vidal; Pierre Casellas
Sigma receptor ligands: applications in inflammation and oncology.
Current opinion in investigational drugs (London, England : 2000) 2004;5(11):1158-63.
2000: Jean-Marie Derocq; Omar Jbilo; Monsif Bouaboula; M Ségui; C Clère; Pierre Casellas
Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation.
The Journal of biological chemistry 2000;275(21):15621-8.
1999: Omar Jbilo; Jean-Marie Derocq; M Segui; Gérard Le-Fur; Pierre Casellas
Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60.
FEBS letters 1999;448(2-3):273-7.
1998: Pierre Carayon; Jean Marchand; Danielle Dussossoy; Jean-Marie Derocq; Omar Jbilo; Annie Bord; Monsif Bouaboula; Sylvaine Galiègue; Paul Mondière; Géraldine Pénarier; G L Fur; Thierry Defrance; Pierre Casellas
Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation.
Blood 1998;92(10):3605-15.
1998: Jean-Marie Derocq; Monsif Bouaboula; Jean Marchand; Murielle Rinaldi-Carmona; M Ségui; Pierre Casellas
The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
FEBS letters 1998;425(3):419-25.
1998: Murielle Rinaldi-Carmona; Francis Barth; J Millan; Jean-Marie Derocq; Pierre Casellas; C Congy; Didier Oustric; M Sarran; Monsif Bouaboula; B Calandra; M Portier; David Shire; J C Brelière; Gérard Le-Fur
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
The Journal of pharmacology and experimental therapeutics 1998;284(2):644-50.
1996: Jean-Marie Derocq; M Ségui; C Blazy; Xavier Emonds-Alt; Gérard Le-Fur; J C Brelire; Pierre Casellas
Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists.
FEBS letters 1996;399(3):321-5.
1996: Bernard Bourrié; J M Benoît; Jean-Marie Derocq; M Esclangon; C Thomas; Gérard Le-Fur; Pierre Casellas
A sigma ligand, SR 31747A, potently modulates Staphylococcal enterotoxin B-induced cytokine production in mice.
Immunology 1996;88(3):389-93.
1996: Jean-Marc Herbert; Alain Lalé; J M Pereillo; Jean-Marie Derocq; Pierre Casellas
Echinomycin suppresses the pyrogenic effects of endotoxin and interleukin-1 beta in human endothelial cells and peripheral blood mononuclear cells.
Thrombosis and haemostasis 1996;75(2):359-62.
1995: B Bourrie; Monsif Bouaboula; J M Benoit; Jean-Marie Derocq; M Esclangon; Gérard Le-Fur; Pierre Casellas
Enhancement of endotoxin-induced interleukin-10 production by SR 31747A, a sigma ligand.
European journal of immunology 1995;25(10):2882-7.
1995: Jean-Marie Derocq; M Ségui; Jean Marchand; Gérard Le-Fur; Pierre Casellas
Cannabinoids enhance human B-cell growth at low nanomolar concentrations.
FEBS letters 1995;369(2-3):177-82.
1995: Jean-Marie Derocq; Bernard Bourrié; M Ségui; Gérard Le-Fur; Pierre Casellas
In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747.
The Journal of pharmacology and experimental therapeutics 1995;272(1):224-30.
1994: Jean-Marie Derocq; M Segui; C Poinot-Chazel; A Minty; Daniel Caput; Pascual Ferrara; Pierre Casellas
Interleukin-13 stimulates interleukin-6 production by human keratinocytes. Similarity with interleukin-4.
FEBS letters 1994;343(1):32-6.
1993: X Canat; A Guillaumont; Monsif Bouaboula; C Poinot-Chazel; Jean-Marie Derocq; Pierre Carayon; G LeFur; Pierre Casellas
Peripheral benzodiazepine receptor modulation with phagocyte differentiation.
Biochemical pharmacology 1993;46(3):551-4.
1993: A Minty; Pascale Chalon; Jean-Marie Derocq; X Dumont; J C Guillemot; Mourad Kaghad; C Labit; P Leplatois; P Liauzun; B Miloux
Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses.
Nature 1993;362(6417):248-50.
1992: F K Jansen; A Jansen; Jean-Marie Derocq; D Carrière; Pierre Carayon; Francisco Veas; Jean-Pierre Jaffrézou
Golgi vacuolization and immunotoxin enhancement by monensin and perhexiline depend on a serum protein. Implications for intracellular trafficking.
The Journal of biological chemistry 1992;267(18):12577-82.
1990: David Shire; Bernard Bourrié; C Carillon; Jean-Marie Derocq; P Dousset; X Dumont; F K Jansen; Mourad Kaghad; R Legoux; P Lelong
Biologically active A-chain of the plant toxin ricin expressed from a synthetic gene in Escherichia coli.
Gene 1990;93(2):183-8.
1989: G Laurent; D Maraninchi; E Gluckman; J P Vernant; Jean-Marie Derocq; M H Gaspard; B Rio; M Michalet; J Reiffers; F Dreyfus
Donor bone marrow treatment with T101 Fab fragment-ricin A-chain immunotoxin prevents graft-versus-host disease.
Bone marrow transplantation 1989;4(4):367-71.
1989: M Chiron; Jean-Marie Derocq; Emilienne Kuhlein; Francis Roubinet; Cécile Demur; H Grandjean; F Huguet; J P Jaffrezou; F Jansen; Guy Laurent
Sensitivity of fresh leukemic cells to T101 ricin A-chain immunotoxin: a comparative study between Fab fragment and whole Ig conjugates.
Leukemia research 1989;13(6):491-9.
1989: Cécile Demur; Jean-Marie Derocq; P Poncelet; M Chiron; Francis Roubinet; J P Jaffrezou; C Bordier; Guy Laurent
Effects of an anti HLA-DR immunotoxin on leukaemia cells and hematopoietic progenitors.
Leukemia research 1989;13(12):1047-54.
1988: Jean-Marie Derocq; Pierre Casellas; G Laurent; S Ravel; Hubert Vidal; F Jansen
Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(8):2837-43.
1988: Pierre Casellas; S Ravel; Bernard Bourrié; Jean-Marie Derocq; F K Jansen; G Laurent; P Gros
T-lymphocyte killing by T101-ricin A-chain immunotoxin: pH-dependent potentiation with lysosomotropic amines.
Blood 1988;72(4):1197-202.
1987: Jean-Marie Derocq; G Laurent; Pierre Casellas; Hubert Vidal; P Poncelet; A Fauser; Cécile Demur; F Jansen
Rationale for the selection of ricin A-chain anti-T immunotoxins for mature T cell depletion.
Transplantation 1987;44(6):763-9.